Ipsen's Monthly Information on Voting Rights
Welcome to this month's detailed update from Ipsen regarding the total number of voting rights and shares that compose its share capital. As a key player in the pharmaceutical sector, keeping our shareholders informed is one of our top priorities.
Understanding the Share Capital Structure
According to the regulations set forth by the French Commercial Code and the General Regulation of the Autorité des Marchés Financiers, it is essential for companies to regularly disclose the status of their share capital. This month, we report that Ipsen is listed on Euronext Paris, with the ISIN Code FR 0010259150, and has an LEI of 549300M6SGDPB4Z94P11.
Key Shareholder Metrics
On the 28th of February, our total number of shares composing the share capital stood at an impressive 83,814,526. This shows our commitment to transparency and is part of our ongoing effort to maintain clear communication with our investors.
Total Voting Rights Breakdown
For our shareholders’ clarity, we have two important figures related to voting rights. The gross total of voting rights amounts to 131,933,057. This figure includes all voting rights associated with each share, counting those shares that possess double voting rights while also accounting for treasury shares.
When we subtract the shares that do not confer voting rights, we arrive at a net total of 130,823,796 voting rights. This distinction is crucial for understanding clearly how many voting rights are effectively available to our shareholders.
Impact of Statutory Clauses
It’s important to highlight that Ipsen's governance includes a statutory clause mandating the declaration of any threshold crossing that exceeds the legal requirements. This reinforces our commitment to compliance and shareholder interests, ensuring every stakeholder is aware of significant changes in shareholding structure.
What This Means for Shareholders
Understanding these nuances about voting rights and shares is crucial for shareholders to make informed decisions. With a healthy number of voting rights, shareholders can participate effectively in corporate governance, aligning their interests with the overall health and future of the company. This continues to show Ipsen’s dedication to maintaining robust investor relationships and governance practices.
Staying Informed
If you are an investor or interested in our movements, it’s crucial to continue keeping an eye on these monthly reports. They offer insights not just into the current standing but also into the overall market dynamics in which Ipsen operates.
Looking Ahead
As we move forward, we remain committed to improving our transparency and communication with shareholders. We encourage all investors to stay updated with our monthly updates and seek further information or clarification as needed.
Frequently Asked Questions
What does the gross total of voting rights represent?
The gross total represents all voting rights linked to shares, including those with double voting rights and treasury shares, providing an overall view of shareholder influence.
How is the net total of voting rights calculated?
The net total is calculated by subtracting shares without voting rights from the gross total, giving a clearer picture of the voting power available to shareholders.
Why is it important to disclose voting rights information?
Transparency in voting rights information helps shareholders understand their influence within the company, fostering trust and informed decision-making.
What is the significance of the statutory clause?
This clause indicates the company's commitment to disclose threshold crossings that exceed legal requirements, ensuring shareholders are informed of significant changes.
Where can I find more information about Ipsen's share capital?
Additional detailed reports are typically published monthly and can usually be found on Ipsen's investor relations website or through company communications.
